Generics News
-
Array BioPharma collaborates with Pfizer
Generics | News | 0 Comment | 20 Dec, 2017
Array BioPharma has announced that it has entered into a clinical trial collaboration agreement with Pfizer to investiga...Read more
-
Sanofi and Regeneron announce positive results for PD-1 antibody
Generics | News | 0 Comment | 14 Dec, 2017
Sanofi and Regeneron has announced positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous s...Read more
-
Sanofi presents R&D strategy and innovative pipeline
Generics | News | 0 Comment | 14 Dec, 2017
Sanofi will host an analyst meeting in Paris today to discuss the company’s Research and Development strategy, dev...Read more
-
Representation disparity in ages below and above 75 years
Generics | News | 0 Comment | 12 Dec, 2017
Singapore - In the first comprehensive analysis of clinical trial enrolment among older adults with blood cancers, resea...Read more
-
Juno Therapeutics signs three license agreements
Generics | News | 0 Comment | 11 Dec, 2017
US based biopharma company Juno Therapeutics has announced three license agreements to advance its program in multiple m...Read more
-
FDA approves Amgen's Repatha (evolocumab)
Generics | News | 0 Comment | 07 Dec, 2017
Amgen has announced that following priority review of its supplemental Biologics License Application, the U.S. Food...Read more
-
Generics | News | 0 Comment | 01 Dec, 2017
Jeong Woo Cho, Ph.D., has been appointed president and CEO of SK biopharmaceuticals and SK life science to lead the comp...Read more
-
Generics | News | 0 Comment | 30 Nov, 2017
Singapore – Janssen Asia Pacific announced it has supported the establishment of the first-of-its-kind Asia Pacifi...Read more
-
Biohaven receives agreement from FDA on initial pediatric study plan
Generics | News | 0 Comment | 28 Nov, 2017
Biohaven Pharmaceutical Holding Company Ltd. has announced that the Company has received agreement from the U.S. Food an...Read more
-
Biogen and Alkermes announce license and collaboration agreement
Generics | News | 0 Comment | 28 Nov, 2017
US based biotech company Biogen and pharma company Alkermes has announced that they have entered into a global lic...Read more
-
GSK submits landmark IMPACT data to USFDA for the use of Trelegy Ellipta
Generics | News | 0 Comment | 27 Nov, 2017
Pharma company, GlaxoSmithKline and Innoviva has announced the filing of a supplemental New Drug Application (sNDA) with...Read more
-
Puma biotech and Specialised Therapeutics signs agreement to commercialize NERLYNX®
Generics | News | 0 Comment | 24 Nov, 2017
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive Licensing Agreement to Commercialize NERLYNX&r...Read more
-
Step Pharma completes €14.5 million Series A financing
Generics | News | 0 Comment | 23 Nov, 2017
France based Step Pharma has announced the closing of a Series A financing totalling €14.5 million. Pontifax will ...Read more
-
FDA approves RxSight's light adjustable lens
Generics | News | 0 Comment | 23 Nov, 2017
Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA...Read more
-
PeptiDream announces collaboration with Bayer
Generics | News | 0 Comment | 21 Nov, 2017
Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaborat...Read more
-
Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen
Generics | News | 0 Comment | 17 Nov, 2017
U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Gener...Read more
-
Cue Biopharma announces research collaboration with Merck
Generics | News | 0 Comment | 17 Nov, 2017
US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and licens...Read more
-
Generic Acticlate tablets launched by Lupin in USA
Generics | News | 0 Comment | 06 Nov, 2017
Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from ...Read more
